Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a non-randomized clinical phase I/II treatment trial studying Fecal Microbiota Transplantation (FMT) + Nivolumab in patients with Non-small-cell lung cancer (NSCLC) (progressive after pretreatment) or Melanoma (cutaneous) (progressive after pretreatment)
Safety, Overall response rate (ORR)
No published results were found as of May 2026
…